Inventor
GRUENINGER FIONA
CH14 patents
⚠️ This page may combine multiple inventors who share the name “GRUENINGER FIONA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
13 patentsUS9290567B2Mar 22, 2016
Use of an anti-Tau pS422 antibody for the treatment of brain diseases
HOFFMANN LA ROCHE25 citations92
US5432069AJul 11, 1995
Tocopherol cyclase isolated from Chlorella protothecoides, Dunaliella salina and wheat leaves
HOFFMANN LA ROCHE43 citations90
US10822402B2Nov 3, 2020
Humanized anti-tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations83
US9862763B2Jan 9, 2018
Humanized anti-tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations83
US10087245B2Oct 2, 2018
Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
HOFFMANN LA ROCHE5 citations81
US10465000B2Nov 5, 2019
Humanized anti-Tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE2 citations72
US9562091B2Feb 7, 2017
Humanized anti-Tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations72
US11124563B2Sep 21, 2021
Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
HOFFMANN LA ROCHE1 citations70
US10538582B2Jan 21, 2020
Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
HOFFMANN LA ROCHE2 citations70
US9738712B2Aug 22, 2017
Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof
HOFFMANN LA ROCHE5 citations70
US12297263B2May 13, 2025
Humanized anti-Tau(PS422) antibodies and methods of use
HOFFMANN LA ROCHE0 citations62
US11572404B2Feb 7, 2023
Humanized anti-Tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE0 citations62
US10787505B2Sep 29, 2020
Oligopeptide and methods for producing conjugates thereof
HOFFMANN LA ROCHE0 citations39